Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

The trend of moving manufacturing to countries like Mexico or Vietnam to avoid China tariffs is often driven by Chinese companies themselves. They establish clone factories abroad, sometimes with Chinese labor, meaning the economic benefits largely still flow back to China.

Related Insights

The move toward a less efficient, more expensive global supply chain is not a failure but a strategic correction. Over-prioritizing efficiency created a dangerous dependency on China. Diversification, while costlier in the short term, is a fundamental principle of long-term risk management.

Despite political pushes for American manufacturing, the reality on Amazon's marketplace is the opposite. Chinese sellers' global share grew from 50% to 57% in one year, indicating that platform dynamics and global supply chains are more powerful forces than nationalistic economic policies like tariffs.

From China's perspective, producing more than it needs and exporting at cutthroat prices is a strategic tool, not an economic problem. This form of industrial warfare is designed to weaken other nations' manufacturing bases, prioritizing geopolitical goals over profit.

The push for supply chain diversification and reduced reliance on China is not a new phenomenon. The COVID-19 pandemic first exposed the critical risks of single-source dependency. Recent tariff threats are not the origin of this strategic realignment but rather a powerful accelerant, forcing companies to act on plans already in motion.

The U.S. industrial strategy isn't pure "reshoring" but "friend-shoring." The goal is to build a global supply chain that excludes China, not to bring all production home. This creates massive investment opportunities in allied countries like Mexico, Vietnam, Korea, and Japan, which are beneficiaries of this geopolitical realignment.

The biopharma outsourcing sector has proven surprisingly resilient to international tariffs. Instead of absorbing costs, well-funded European companies are bypassing tariffs altogether by investing in and building new production facilities directly on U.S. soil, effectively onshoring their manufacturing.

China does not oppose the migration of labor-intensive manufacturing to ASEAN countries. With an aging workforce, its strategic focus is shifting up the value chain to high-end industries like green energy. This indicates a deliberate industrial policy to cede low-cost production rather than a desire to control all levels of manufacturing.

A flat tariff on imports makes complex manufacturing with numerous cross-border steps prohibitively expensive. It becomes cheaper to move domestic production steps out of the tariff zone and import the finished good only once, leading to the deindustrialization of high-skilled jobs.

Geopolitical shifts mean a company's country of origin heavily influences its market access and tariff burdens. This "corporate nationality" creates an uneven playing field, where a business's location can instantly become a massive advantage or liability compared to competitors.

Despite significant US tariffs hitting labor-intensive goods, China's overall export volume remains strong. This resilience stems from a structural shift towards high-tech sectors like semiconductors and autos, combined with strategically rerouting trade through intermediary ASEAN countries to circumvent direct tariffs.